Quercetin Mediated TET1 Expression Through MicroRNA-17 Induced Cell Apoptosis in Melanoma Cells

Overview

Journal Biochem Genet

Specialty Molecular Biology

Date 2022 Sep 22

PMID 36136257

Authors

Yongjian Gao

Chengshun Li

Tianyi Xue

Chao Lin

Ruizhi Hou

Qianyun Xia

Dayong Ding

Jiaqi Li

Dongxu Wang

Ye Feng

Affiliations

Soon will be listed here.

Abstract

A previous report suggested that the expression of ten-eleven translocation (TET) proteins is abnormal in certain cancers. Quercetin has been demonstrated as anti-cancer role in cancer development. In order to explore the inhibitory effect and mechanism of quercetin on uveal melanoma cells, the expression of TET proteins was analyzed in the present study. Our results suggest that the expression of TET1 was increased following treatment with quercetin in OCM-1, SK-MEL-1, and B16 cells. In addition, quercetin treatment induced apoptosis and inhibited migration and invasion. To further investigate the association of the expression of TET1 with cell growth, apoptosis, migration, and invasion, cell lines in which TET1 was knocked-down or overexpressed were constructed. The results showed that the increased expression of TET1-induced apoptosis, increased 5-hydroxymethylcytosine (5 hmC). and inhibited invasion. Our bioinformatics studies indicated that TET1 is a target gene of microRNA-17 (miR-17) Our results showed that inhibition of the expression of miR-17 resulted in increased TET1 expression in OCM-1 cells. Furthermore, our results indicated that quercetin treatment increased TET1 expression and inhibited melanoma growth in nude mice. Taken together, our results suggest that quercetin can regulate cell proliferation and apoptosis through TET1 via miR-17 in melanoma cells.

Citing Articles

Quercetin in Oncology: A Phytochemical with Immense Therapeutic Potential.

Kamal R, Paul P, Thakur S, Singh S, Awasthi A Curr Drug Targets. 2024; 25(11):740-751.

PMID: 38988154 DOI: 10.2174/0113894501292466240627050638.

Nanoformulations of quercetin for controlled delivery: a review of preclinical anticancer studies.

Joshi H, Gupta D, Kaur G, Singh T, Ramniwas S, Sak K Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(12):3443-3458.

PMID: 37490121 DOI: 10.1007/s00210-023-02625-z.

References

Alavi M, Adulrahman N, Haleem A, Al-Rawanduzi A, Khusro A, Abdelgawad M . Nanoformulations of curcumin and quercetin with silver nanoparticles for inactivation of bacteria. Cell Mol Biol (Noisy-le-grand). 2022; 67(5):151-156. DOI: 10.14715/cmb/2021.67.5.21. View

Chen L, Li Q, Jiang Z, Li C, Hu H, Wang T . Chrysin Induced Cell Apoptosis Through /let-7a/ Axis in Gastric Cancer Cells and Inhibited Tumor Growth. Front Oncol. 2021; 11:651644. PMC: 8209501. DOI: 10.3389/fonc.2021.651644. View

de Oliveira M, Nabavi S, Braidy N, Setzer W, Ahmed T, Nabavi S . Quercetin and the mitochondria: A mechanistic view. Biotechnol Adv. 2016; 34(5):532-549. DOI: 10.1016/j.biotechadv.2015.12.014. View

Ding C, Li L, Yang T, Fan X, Wu G . Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model. BMC Cancer. 2016; 16(1):791. PMC: 5059930. DOI: 10.1186/s12885-016-2834-8. View

Gao M, Tang J, Liu K, Yang M, Liu H . Quantitative Evaluation of Vascular Microcirculation Using Contrast-Enhanced Ultrasound Imaging In Rabbit Models of Choroidal Melanoma. Invest Ophthalmol Vis Sci. 2018; 59(3):1251-1262. DOI: 10.1167/iovs.17-22197. View

Jiang Y, He J, Guo Y, Tao H, Pu F, Li Y . Identification of genes related to low-grade glioma progression and prognosis based on integrated transcriptome analysis. J Cell Biochem. 2019; 121(5-6):3099-3111. DOI: 10.1002/jcb.29577. View

Harris Z, Donovan M, Branco G, Limesand K, Burd R . Quercetin as an Emerging Anti-Melanoma Agent: A Four-Focus Area Therapeutic Development Strategy. Front Nutr. 2016; 3:48. PMC: 5086580. DOI: 10.3389/fnut.2016.00048. View

He Y, Li B, Li Z, Liu P, Wang Y, Tang Q . Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science. 2011; 333(6047):1303-7. PMC: 3462231. DOI: 10.1126/science.1210944. View

Huang Y, Rao A . Connections between TET proteins and aberrant DNA modification in cancer. Trends Genet. 2014; 30(10):464-74. PMC: 4337960. DOI: 10.1016/j.tig.2014.07.005. View

10.

Khan I, Paul S, Jakhar R, Bhardwaj M, Han J, Kang S . Novel quercetin derivative TEF induces ER stress and mitochondria-mediated apoptosis in human colon cancer HCT-116 cells. Biomed Pharmacother. 2016; 84:789-799. DOI: 10.1016/j.biopha.2016.09.094. View

11.

Kocyigit A, Guler E . Curcumin induce DNA damage and apoptosis through generation of reactive oxygen species and reducing mitochondrial membrane potential in melanoma cancer cells. Cell Mol Biol (Noisy-le-grand). 2017; 63(11):97-105. DOI: 10.14715/cmb/2017.63.11.17. View

12.

Tsai Y, Lai C, Huang T, Hsieh C, Huang E, Lee Y . Association of malnutrition with postoperative complication risk after curative surgery for oral cancer: Observational study. Medicine (Baltimore). 2020; 99(52):e23860. PMC: 7769301. DOI: 10.1097/MD.0000000000023860. View

13.

Li R, Zhou Y, Cao Z, Liu L, Wang J, Chen Z . TET2 Loss Dysregulates the Behavior of Bone Marrow Mesenchymal Stromal Cells and Accelerates Tet2-Driven Myeloid Malignancy Progression. Stem Cell Reports. 2018; 10(1):166-179. PMC: 5768963. DOI: 10.1016/j.stemcr.2017.11.019. View

14.

Li Y, He J, Qiu C, Shang Q, Qian G, Fan X . The oncolytic virus H101 combined with GNAQ siRNA-mediated knockdown reduces uveal melanoma cell viability. J Cell Biochem. 2018; 120(4):5766-5776. DOI: 10.1002/jcb.27863. View

15.

Massi A, Bortolini O, Ragno D, Bernardi T, Sacchetti G, Tacchini M . Research Progress in the Modification of Quercetin Leading to Anticancer Agents. Molecules. 2017; 22(8). PMC: 6152094. DOI: 10.3390/molecules22081270. View

16.

Nesvet J, Rizzi G, Wang S . Highly sensitive detection of DNA hypermethylation in melanoma cancer cells. Biosens Bioelectron. 2018; 124-125:136-142. PMC: 6245664. DOI: 10.1016/j.bios.2018.10.018. View

17.

Orgaz J, Sanz-Moreno V . Emerging molecular targets in melanoma invasion and metastasis. Pigment Cell Melanoma Res. 2012; 26(1):39-57. DOI: 10.1111/pcmr.12041. View

18.

Shi Y, Liu G, Li S, Liu X . miR-17-5p knockdown inhibits proliferation, autophagy and promotes apoptosis in thyroid cancer via targeting PTEN. Neoplasma. 2020; 67(2):249-258. DOI: 10.4149/neo_2019_190110N29. View

19.

Shi Z, Li N, Tang Y, Shi Q, Zhang W, Zhang P . Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer. Bioorg Med Chem Lett. 2014; 24(18):4424-4427. DOI: 10.1016/j.bmcl.2014.08.006. View

20.

Song J, Liu Y, Wang T, Li B, Zhang S . MiR-17-5p promotes cellular proliferation and invasiveness by targeting RUNX3 in gastric cancer. Biomed Pharmacother. 2020; 128:110246. DOI: 10.1016/j.biopha.2020.110246. View